SC
KMTS

Steven Cohen’s Kestra Medical Technologies KMTS Stock Holding History

Steven Cohen’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Buy
+526,626
New +$11M 0.01% 1107
2025
Q3 		– Sell
-50,900
Closed -$844K – 2769
2025
Q2 		$844K Buy
+50,900
New +$1.11M ﹤0.01% 1615

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Steven Cohen's KMTS Position: Q2 2026 in Review

Steven Cohen opened a new position in Kestra Medical Technologies (KMTS) in Q2 2026: 526,626 shares worth $13.4M. The stake represents 0.01% of the portfolio and ranks #1107 among its holdings. This is a return to the name: Steven Cohen previously reported a position in KMTS as recently as Q2 2025.

Steven Cohen first reported a position in KMTS in Q2 2025 and has held it in 2 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Steven Cohen held 526,626 shares of Kestra Medical Technologies worth $13.4M as of Q2 2026.
  • Kestra Medical Technologies was a new Steven Cohen position in Q2 2026.
  • Kestra Medical Technologies made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1107 holding.
  • Steven Cohen first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 2 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.